1 |
The emerging role of targeting cancer metabolism for cancer therapy |
|
|
| Pegah Farhadi, Reza Yarani, Sadat Dokaneheifard, Kamran Mansouri |
|
| Tumor Biology. 2020; 42(10): 1010428320 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
2 |
Detection of COX-2 in liquid biopsy in patients with breast cancer |
|
|
| Camilla Paulla de Souza, Beatriz Alves, Jaques Waisberg, Fernando Fonseca, Alipio de Oliveira Carmo, Flavia Gehrke |
|
| Journal of Clinical Pathology. 2020; 73(12): 826 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
3 |
Cross-Talk between Cancer Cells and the Tumour Microenvironment: The Role of the 5-Lipoxygenase Pathway |
|
|
| Gillian Moore,Graham Pidgeon |
|
| International Journal of Molecular Sciences. 2017; 18(2): 236 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
4 |
A Sucrose-Enriched Diet Promotes Tumorigenesis in Mammary Gland in Part through the 12-Lipoxygenase Pathway |
|
|
| Yan Jiang, Yong Pan, Patrea R. Rhea, Lin Tan, Mihai Gagea, Lorenzo Cohen, Susan M. Fischer, Peiying Yang |
|
| Cancer Research. 2016; 76(1): 24 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
5 |
Expression of Cox-2 and Bcl-2 in Pagetæs Disease of the Breast |
|
|
| Arsenal Sezgin Alikanoglu,Mustafa Yildirim,Dinc Suren,Birsel Tutus,Vildan Kaya,Cumhur Selcuk Topal,Sevinc Keser,Ayse Nimet Karadayi,Fatma Nilgun Kapucuoglu,Sebnem Ayva,Seyda Gunduz |
|
| Asian Pacific Journal of Cancer Prevention. 2015; 16(3): 1041 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
6 |
Cyclooxygenase-2 Expression in Invasive Breast Carcinomas of No Special Type and Correlation with Pathological Profiles Suggest a Role in Tumorigenesis Rather than Cancer Progression |
|
|
| Nurul Akmar Misron,Lai-Meng Looi,Nik Raihan Nik Mustapha |
|
| Asian Pacific Journal of Cancer Prevention. 2015; 16(4): 1553 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
7 |
Receptor-Defined Subtypes of Breast Cancer in Indigenous Populations in Africa: A Systematic Review and Meta-Analysis |
|
|
| Amanda Eng,Valerie McCormack,Isabel dos-Santos-Silva,Hans-Olov Adami |
|
| PLoS Medicine. 2014; 11(9): e1001720 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
8 |
Associations betweenALOX,COX, andCRPpolymorphisms and breast cancer among Hispanic and non-Hispanic white women: The breast cancer health disparities study |
|
|
| Avonne E. Connor,Richard N. Baumgartner,Kathy B. Baumgartner,Christina M. Pinkston,Stephanie D. Boone,Esther M. John,Gabriela Torres- Mejía,Lisa M. Hines,Anna R. Giuliano,Roger K. Wolff,Martha L. Slattery |
|
| Molecular Carcinogenesis. 2014; : n/a |
|
| [Pubmed] [Google Scholar] [DOI] |
|
9 |
The Obesity-Inflammation-Eicosanoid Axis in Breast Cancer |
|
|
| Linda Vona-Davis,David P. Rose |
|
| Journal of Mammary Gland Biology and Neoplasia. 2013; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
10 |
Fatty Acid Metabolites in Rapidly Proliferating Breast Cancer |
|
|
| OæFlaherty, J.T. and Wooten, R.E. and Samuel, M.P. and Thomas, M.J. and Levine, E.A. and Case, L.D. and Akman, S.A. and Edwards, I.J. |
|
| PLoS ONE. 2013; 8(5) |
|
| [Pubmed] [Google Scholar] |
|
11 |
Fatty Acid Metabolites in Rapidly Proliferating Breast Cancer |
|
|
| Joseph T. O’Flaherty,Rhonda E. Wooten,Michael P. Samuel,Michael J. Thomas,Edward A. Levine,L. Douglas Case,Steven A. Akman,Iris J. Edwards,Anthony Peter Sampson |
|
| PLoS ONE. 2013; 8(5): e63076 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
12 |
Rutin inhibits B[a]PDE-induced cyclooxygenase-2 expression by targeting EGFR kinase activity |
|
|
| Seunghwan Choi,Tae-Gyu Lim,Mun Kyung Hwang,Yoon-A Kim,Jiyoung Kim,Nam Joo Kang,Tae Su Jang,Jun-Seong Park,Myeong Hun Yeom,Ki Won Lee |
|
| Biochemical Pharmacology. 2013; 86(10): 1468 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
13 |
Clinical relevance of cyclooxygenase-2 and matrix metalloproteinases (MMP-2 and MT1-MMP) in human breast cancer tissue |
|
|
| Mohammad A. Mohammad, Ahmed A. Zeeneldin, Zakaria Y. Abd Elmageed, Ebtsam H. Khalil, Said M. E. Mahdy, Hayat M. Sharada, Sabry K. Sharawy, Abdel-Hady A. Abdel-Wahab |
|
| Molecular and Cellular Biochemistry. 2012; |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
14 |
Association of a functional polymorphism (Gln261Arg) in 12-lipoxygenase with breast cancer |
|
|
| Prasad, V.V.T.S. and Kolli, P. and Moganti, D. |
|
| Experimental and Therapeutic Medicine. 2011; 2(2): 317-323 |
|
| [Pubmed] [Google Scholar] |
|
15 |
Cyclooxygenase-2 and human epidermal growth factor receptor type 2 (HER-2) expression simultaneously in invasive and in situ breast ductal carcinoma [Expressão da ciclo-oxigenase-2 e receptor tipo 2 do fator de crescimento epidérmico humano (HER-2) simultaneamente em carcinoma ductal de mama in situ e invasivo] |
|
|
| Lucarelli, A.P. and Martins, M.M. and Montor, W. and Oliveira, V. and Galvão, M.A.L. and Piato, S. |
|
| Sao Paulo Medical Journal. 2011; 129(6): 371-379 |
|
| [Pubmed] [Google Scholar] |
|
16 |
Discovery of potent and selective inhibitors of human platelet-type 12-lipoxygenase |
|
|
| Kenyon, V. and Rai, G. and Jadhav, A. and Schultz, L. and Armstrong, M. and Jameson, J.B. and Perry, S. and Joshi, N. and Bougie, J.M. and Leister, W. and Taylor-Fishwick, D.A. and Nadler, J.L. and Holinstat, M. and Simeonov, A. and Maloney, D.J. and Holman, T.R. |
|
| Journal of Medicinal Chemistry. 2011; 54(15): 5485-5497 |
|
| [Pubmed] [Google Scholar] |
|
17 |
Discovery of Potent and Selective Inhibitors of Human Platelet-Type 12- Lipoxygenase |
|
|
| |
|
| Journal of Medicinal Chemistry. 2011; 54(15): 5485 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
18 |
COX2 overexpression is a prognostic marker for Stage III breast cancer |
|
|
| Hee Sung Kim, Hyeong-Gon Moon, Wonshik Han, Cha Kyung Yom, Woo Ho Kim, Jun Ho Kim, Dong-Young Noh |
|
| Breast Cancer Research and Treatment. 2011; |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
19 |
Expression of cyclooxygenase-2 (COX-2) and p53 in neighboring invasive and in situ components of breast tumors |
|
|
| Katia Piton Serra, Luis Otavio Sarian, Raquel Mary Rodrigues-Peres, José Vassallo, Fernando Augusto Soares, Glauce Aparecida Pinto, Isabela Werneck da Cunha, Julia Yoriko Shinzato, Sophie F.M. Derchain |
|
| Acta Histochemica. 2011; |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
20 |
Cyclooxygenase-2 and human epidermal growth factor receptor type 2 (HER-2) expression simultaneously in invasive and in situ breast ductal carcinoma |
|
|
| Adrienne Pratti Lucarelli,Maria Marta Martins,Wagner Montor,Vilmar Oliveira,Maria Antonieta Longo Galvão,Sebastião Piato |
|
| Sao Paulo Medical Journal. 2011; 129(6): 371 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
21 |
Association of a functional polymorphism (Gln261Arg) in 12-lipoxygenase with breast cancer |
|
|
| VIDUDALA V.T.S. PRASAD,PADMA KOLLI,DIVYA MOGANTI |
|
| Experimental and Therapeutic Medicine. 2011; 2(2): 317 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
22 |
ALOX12 gene is associated with the onset of natural menopause in white women : |
|
|
| Pengyuan Liu, Yan Lu, Robert R. Recker, Hong-Wen Deng, Volodymyr Dvornyk |
|
| Menopause. 2010; 17(1): 152-156 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
23 |
Association between polymorphisms of arachidonate 12-lipoxygenase (ALOX12) and schizophrenia in a Korean population |
|
|
| Kim, T. and Kim, H.-J. and Park, J.K. and Kim, J.W. and Chung, J.-H. |
|
| Behavioral and Brain Functions. 2010; 6(44) |
|
| [Pubmed] [Google Scholar] |
|
24 |
The value of COX-2 expression in the prognostic parameters of invasive ductal carcinoma of the breast |
|
|
| Nagehan Ozdemir Barısık, Sevinc Hallac Keser, Aylin Ege Gul, Sibel Sensu, Nilufer Onak Kandemir, Hasan Fehmi Kucuk, Mahmut Gumus, Nimet Karadayı |
|
| Medical Oncology. 2010; |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
25 |
Clinical use and pharmacological properties of selective COX-2 inhibitors |
|
|
| Shaojun Shi,Ulrich Klotz |
|
| European Journal of Clinical Pharmacology. 2008; 64(3): 233 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
26 |
Clinical use and pharmacological properties of selective COX-2 inhibitors |
|
|
| Shi, S. and Klotz, U. |
|
| European Journal of Clinical Pharmacology. 2008; 64(3): 233-252 |
|
| [Pubmed] [Google Scholar] |
|